Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
Pere Millat-Martínez, Arvind Gharbharan, Andrea Alemany, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 375
Therapeutic advances in COVID-19
Naoka Murakami, Robert Hayden, Thomas Hills, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 38-52
Open Access | Times Cited: 126
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Lise J Estcourt, Claudia S. Cohn, Monica B. Pagano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1310-1321
Open Access | Times Cited: 63
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Outpatient randomized controlled trials to reduce COVID‐19 hospitalization: Systematic review and meta‐analysis
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 19
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, et al.
EBioMedicine (2025) Vol. 113, pp. 105613-105613
Open Access
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
Sixten Körper, Beate Grüner, Daniel Zickler, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 24
Open Access | Times Cited: 21
Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trials
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 16
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19
Tayler A. Van Denakker, Arwa Z. Al‐Riyami, Rita Feghali, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 7, pp. 501-514
Closed Access | Times Cited: 7
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far
Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, et al.
Hämostaseologie (2023) Vol. 43, Iss. 01, pp. 067-074
Open Access | Times Cited: 5
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays
Maurice Steenhuis, Elise Wouters, Hubert Schrezenmeier, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 8, pp. 666-673
Closed Access | Times Cited: 5
Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
Pei Ye Li, Philip S. Yu, Allen Li, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100068-100068
Open Access | Times Cited: 4
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)
Marc Hilhorst, Fréderike J. Bemelman, Annette Bruchfeld, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 8, pp. 1807-1816
Closed Access | Times Cited: 4
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, et al.
BMJ Open (2023) Vol. 13, Iss. 4, pp. e071277-e071277
Open Access | Times Cited: 4
Clinical and Virological Response to Convalescent Plasma in a Chronic Lymphocytic Leukemia Patient with COVID-19 Pneumonia
Giovanni Belcari, Alberto Conti, Alessandro Mazzoni, et al.
Life (2022) Vol. 12, Iss. 7, pp. 1098-1098
Open Access | Times Cited: 6
Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial
Andrea Alemany, Pere Millat-Martínez, Marc Corbacho-Monné, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101898-101898
Open Access | Times Cited: 3
Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
Cindy Ke Zhou, Monica Bennett, Carlos H. Villa, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273223-e0273223
Open Access | Times Cited: 5
Coronavirus Disease 2019 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle
Shmuel Shoham
Clinical Infectious Diseases (2023) Vol. 76, Iss. 12, pp. 2087-2089
Closed Access | Times Cited: 1
Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe
Daniele Focosi, Massimo Franchini
Life (2022) Vol. 12, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 1
Page 1

Scroll to top